Tumor Microenvironment Modulating Functional Nanoparticles for Effective Cancer Treatments

Area of Science:

• Oncology
• Nanomedicine
• Tumor Biology

Background:

• Cancer remains a leading global health threat, with treatment resistance a significant challenge.
• Conventional therapies like chemotherapy and immunotherapy face limitations due to cancer cell resistance mechanisms.
• The tumor microenvironment (TME), characterized by hypoxia, acidity, and immunosuppression, plays a crucial role in treatment resistance.

Purpose of the Study:

• To review the latest strategies for effective cancer treatment utilizing functional nanoparticles.
• To explore how functional nanoparticles can modulate the tumor microenvironment (TME) to overcome treatment resistance.
• To highlight the potential of nanoparticle-TME interactions in enhancing cancer therapeutics.

Main Methods:

• Review of preclinical studies on functional nanoparticles targeting the TME.
• Analysis of nanoparticle-mediated modulation of TME characteristics (hypoxia, acidity, etc.).
• Synthesis of current research on combining functional nanoparticles with existing cancer therapies.

Main Results:

• Preclinical evidence demonstrates that functional nanoparticles can effectively modulate the TME.
• Functional nanoparticles show potential in treating refractory cancers by overcoming resistance mechanisms.
• Modulating the TME with nanoparticles enhances the efficacy of various anticancer treatments.

Conclusions:

• Functional nanoparticles represent a promising strategy for overcoming cancer treatment resistance.
• Targeting and modulating the TME with nanoparticles can significantly improve therapeutic outcomes.
• Combining functional nanoparticles with modern cancer therapeutics is expected to maximize treatment efficiency.